Christopher I. Li

Appointments and Affiliations

 
 
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Program in Epidemiology
Full Member, Appointed: 2010
University of Washington
School of Public Health and Community Medicine
Epidemiology
Research Associate Professor, Appointed: 2006
Professional Headshot of Christopher I. Li

Mailing Address

1100 Fairview Ave. N.
P.O. Box 19024
M4-C308
Seattle, Washington 98109-1024
United States

Contact

Phone: (206) 667-7444
Fax: (206) 667-5948
cili@fhcrc.org
http://labs.fhcrc.org/li/index.html
 

Degrees

Ph.D., University of Washington, Epidemiology, 2002.
M.P.H., University of Washington, Epidemiology, 2000.
M.D., University of California, San Francisco, 2000.
B.S., Stanford University, Biological Sciences, 1995.

Research Interests

My research interests lie principally in the field of breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. I am actively investigating the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers. I am also interested in breast cancer outcomes and am currently leading studies that investigate risk factors for second primary breast cancer among breast cancer survivors. Another part of my work focuses on identifying markers that could be used for the early detection of different cancers using various proteomic platforms. Finally, I have an interest in examining disparities in cancer stage, treatment, and survival by race/ethnicity.

Languages

(Reading, Writing, Speaking)

Spanish: (Basic, Basic, Basic)

Memberships

American Association for Cancer Research

Previous Positions

2006-2010, Associate Member, Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Program in Epidemiology

 

Recent Publications

2016
2015
Chen L, Malone KE, Li CI.  2015.  Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(9):1423-1426. Abstract
Chen L, Li CI.  2015.  Racial Disparities in Breast Cancer Diagnosis and Treatment by Hormone Receptor and HER2 Status.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(11):1666-1672. Abstract
Pepe MS, Li CI, Feng Z.  2015.  Improving the Quality of Biomarker Discovery Research: The Right Samples and Enough of Them.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2014
Chen L, Malone KE, Li CI.  2014.  Bra wearing not associated with breast cancer risk: a population-based case-control study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(10):2181-5. Abstract
Beaber EF, Malone KE, Tang M-TC, Barlow WE, Porter PL, Daling JR, Li CI.  2014.  Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(5):755-64. Abstract
Pepe MS, Janes H, Li CI.  2014.  Net risk reclassification p values: valid or misleading? Journal of the National Cancer Institute. 106(4):dju041. Abstract
2013
McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.  2013.  Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1529-37. Abstract